2022
DOI: 10.1016/j.rvsc.2021.12.023
|View full text |Cite|
|
Sign up to set email alerts
|

Identification of Cytotoxic T lymphocyte (CTL) Epitope and design of an immunogenic multi-epitope of Bovine Ephemeral Fever Virus (BEFV) Glycoprotein G for Vaccine Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…However, ORFV's zoonotic nature and robust immune response in both humans and ruminants and its interaction with HLA may suggest the possibility of putative epitopes ( Rohde et al., 2012 ; Bergqvist et al., 2017 ; Demiraslan et al., 2017 ; Wang et al., 2019 ). We referred to studies on zoonosis and other animal diseases that used known MHC phenotypes for epitope screening ( Palanisamy and Lennerstrand, 2017 ; Joshi et al., 2021 ; Mollazadeh et al., 2022 ; Soltan et al., 2022 ). These candidate epitopes could be considered for vaccine development involving host cell immunity.…”
Section: Discussionmentioning
confidence: 99%
“…However, ORFV's zoonotic nature and robust immune response in both humans and ruminants and its interaction with HLA may suggest the possibility of putative epitopes ( Rohde et al., 2012 ; Bergqvist et al., 2017 ; Demiraslan et al., 2017 ; Wang et al., 2019 ). We referred to studies on zoonosis and other animal diseases that used known MHC phenotypes for epitope screening ( Palanisamy and Lennerstrand, 2017 ; Joshi et al., 2021 ; Mollazadeh et al., 2022 ; Soltan et al., 2022 ). These candidate epitopes could be considered for vaccine development involving host cell immunity.…”
Section: Discussionmentioning
confidence: 99%
“…Since no HTL epitopes were assigned due to the lack of a complete characterization of bovine MHC II molecules, only CTL and B cell epitopes were used to construct a multi-epitope vaccine (Mollazadeh et al 2022 ). Immunogenic, non-allergenic, antigenic, and non-toxic epitopes were selected among these epitopes because they should elicit an immune response without endangering the host.…”
Section: Resultsmentioning
confidence: 99%